Clinical trial
Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil…
NCT00228020 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00228020 |
|---|---|
| Title | Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients |
| Official title | A Randomized, Placebo-controlled, Double-blind, Multicenter Study Investigating Basiliximab in Combination With MMF, Cyclosporine Microemulsion and Prednisone in the Prevention of Acute Rejection in Pediatric Renal Allograft Recipients |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pediatric Kidney Transplantation |
| Intervention type | Drug |
| Interventions | basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent), MMF, steroids |
| Enrollment | 212 |
| Start date | May 1, 2001 |
| Primary completion | Jan 1, 2006 |
| First posted | Sep 28, 2005 |
| Last update posted | Aug 25, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: